ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JBTM vs TMO // OPERATING MARGIN

JBT Marel Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: JBTM 5 — TMO 8
▲ OPERATING MARGIN LEADER: TMO
operating-margins
5.00%
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBTM VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JBTM TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 35.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 2.60% 9.30% -6.70 TMO /roic <GO>
EV/EBITDA & P/E Valuation 21.0x 30.4x -9.40 JBTM /valuation <GO>
Free Cash Flow Yield -3.99% 2.40% -6.39 TMO /fcf-yield <GO>
Operating Margin ACTIVE 5.00% 17.40% -12.40 TMO /operating-margins <GO>
Net Profit Margin -1.30% 15.10% -16.40 TMO /net-margins <GO>
Revenue Growth (YoY) 121.30% 3.90% +117.40 JBTM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.36% 0.24% +0.12 JBTM /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.66 4.50 -2.84 TMO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.2 62.9 -8.70 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.99 0.94 +0.05 JBTM /macro-sensitivity <GO>
Forward P/E Multiple 18.0x 36.3x -18.30 JBTM /forward-pe <GO>
Enterprise Scale & Market Cap $5.73B $262.22B -$256.49B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JBTM REV TMO REV JBTM GROSS % TMO GROSS % JBTM FCF TMO FCF
FY 2025 $3.80B $44.56B 35.1% — — $6.29B
FY 2024 $1.72B $42.88B 36.5% — — $7.27B
FY 2023 $1.66B $42.86B — — — $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBTM // BETA 0.99
TMO // BETA 0.94